
HCAT Stock Forecast & Price Target
HCAT Analyst Ratings
Bulls say
Health Catalyst is a leader in helping healthcare providers address and reduce spending waste, improve efficiency, and close gaps in care. With a strong focus on data and analytics technology, the company offers a customizable modular framework and professional services to help providers deliver measurable improvements in clinical, financial, and operational outcomes. The company has a large addressable market and a strong track record of success, making it a sound investment for those looking to capitalize on the growing demand for healthcare solutions.
Bears say
Health Catalyst is facing several challenges, including a challenging end market, negative mix shift, and potential customer loss that could affect their financials. With a longer sales cycle and increased competition in the healthcare data and analytics industry, there is a risk to the company's profitability and ability to grow. The potential divestiture of assets could create shareholder value, but a lack of transparency and guidance makes it difficult to accurately predict the company's future performance. The stock is currently trading at a discount to its peers, and while there may be opportunities for growth with a more efficient and aligned organization, executing on this without sufficient resources and a depressed stock price presents challenges.
This aggregate rating is based on analysts' research of Health Catalyst Inc and is not a guaranteed prediction by Public.com or investment advice.
HCAT Analyst Forecast & Price Prediction
Start investing in HCAT
Order type
Buy in
Order amount
Est. shares
0 shares